Previous Emergency Response Funding
Previous CDC Response Funding to State and Local Jurisdictions
Since 2009, CDC has provided state, local, and territorial jurisdictions with supplemental funding to support emergency response using a variety of funding mechanisms.
In response to the H1N1 pandemic, CDC awarded $1.4 billion in four phrases in 2009 and 2010 through the Public Health Emergency Response (PHER) grant. These funds upgrade state and local pandemic inﬂuenza preparedness and response capacity. Congress appropriated the funding in June 2009 through the 2009 Supplemental Appropriations Act for the “Public Health and Social Services Emergency Fund” to prepare for and respond to ongoing and emerging outbreaks of novel H1N1 inﬂuenza in the United States.
In April 2015, CDC awarded $145 million in Ebola emergency funding as a supplement to the PHEP cooperative agreement for accelerated Ebola preparedness and response activities. This funding was a portion of the emergency supplemental funding appropriated by Congress in December 2014 for Ebola treatment and prevention in the United States and West Africa. Prior to that, CDC awarded $4.7 million in PHEP Ebola supplemental funding to support development and implementation of active monitoring (AM) and direct active monitoring (DAM) of travelers who may have been exposed to Ebola. This initially funding came from the 2014 National Security Special Event (NSSE) fund.
In July 2016, CDC awarded $25 million in through the Public Health Preparedness and Response (PHPR) funding mechanism to 53 states, cities, and territories. This funding supported eﬀorts to protect Americans from Zika virus infection and associated adverse health outcomes, including microcephaly and the other serious birth defects. The funding was made available following a reprogramming of PHEP funds. Later, in December 2016, CDC awarded an additional $25 million in PHPR funding to 21 states, cities, and territories at greatest risk of seeing Zika in their communities to support eﬀorts to protect Americans from Zika virus infection and associated adverse health outcomes, including microcephaly and the other serious birth defects. These funds were part of the $350 million Congress provided to CDC as part of the Zika supplemental funding appropriation.